Sanofi to pay US$11.9m to resolve US drug kickback probe
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BOSTON] Sanofi SA has agreed to pay nearly US$11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.
The US Justice Department on Friday said Sanofi was the latest company to settle claims stemming from an industry-wide probe of drugmakers' financial support of patient assistance charities.
Sanofi did not admit wrongdoing as part of the settlement.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Middle East-linked energy supply shocks put Asean Power Grid back in focus
From intern to C-suite: JPMorgan’s Teresa Heitsenrether on building a fully AI-powered ‘megabank’
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Prime Orchard condo High Point takes fifth stab at en bloc sale with S$580 million asking price
